Unichem Laboratories (NSE:UNICHEMLAB) Short Ratio


NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
74 GF Score
Price ₹638.75
GF Value ₹691.68
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Unichem Laboratories Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:UNICHEMLAB
74GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹638.75 is trading 7.7% below its estimated GF Value™ of ₹691.68. GuruFocus considers Unichem Laboratories to be Fairly Valued.

Key valuation signals for NSE:UNICHEMLAB:

  • Short Ratio:
  • GF Value™: ₹691.68 vs. price of ₹638.75 (7.7% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
74GF Score

Get the complete analysis for NSE:UNICHEMLAB

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹638.75
Price
₹691.68
GF Value